Kolitha Basnayake

1.1k total citations
18 papers, 731 citations indexed

About

Kolitha Basnayake is a scholar working on Molecular Biology, Nephrology and Hematology. According to data from OpenAlex, Kolitha Basnayake has authored 18 papers receiving a total of 731 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Nephrology and 8 papers in Hematology. Recurrent topics in Kolitha Basnayake's work include Amyloidosis: Diagnosis, Treatment, Outcomes (9 papers), Multiple Myeloma Research and Treatments (6 papers) and Renal Diseases and Glomerulopathies (5 papers). Kolitha Basnayake is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (9 papers), Multiple Myeloma Research and Treatments (6 papers) and Renal Diseases and Glomerulopathies (5 papers). Kolitha Basnayake collaborates with scholars based in United Kingdom, United States and Germany. Kolitha Basnayake's co-authors include Paul Cockwell, Colin A. Hutchison, A.R. Bradwell, Stephen Harding, Stephanie Stringer, Wei‐Zhong Ying, Paul W. Sanders, Mark Cook, Mark T. Drayson and Melpomeni Kountouri and has published in prestigious journals such as Blood, Kidney International and Journal of the American Society of Nephrology.

In The Last Decade

Kolitha Basnayake

17 papers receiving 710 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kolitha Basnayake United Kingdom 13 445 374 233 126 110 18 731
DJ Roe United States 6 208 0.5× 142 0.4× 121 0.5× 321 2.5× 40 0.4× 11 564
Julie Abraham France 13 233 0.5× 108 0.3× 73 0.3× 129 1.0× 73 0.7× 32 687
Zheng Tang China 16 178 0.4× 51 0.1× 264 1.1× 125 1.0× 29 0.3× 51 796
Guillaume Bollée France 17 388 0.9× 37 0.1× 394 1.7× 60 0.5× 57 0.5× 34 988
Carlos M. de Castro United States 15 247 0.6× 228 0.6× 38 0.2× 111 0.9× 91 0.8× 65 1.3k
Mansour Alfayez United States 15 233 0.5× 410 1.1× 93 0.4× 161 1.3× 158 1.4× 54 775
Claudio Ponticelli Italy 14 155 0.3× 82 0.2× 600 2.6× 38 0.3× 114 1.0× 39 959
Y Beguin Belgium 19 117 0.3× 698 1.9× 63 0.3× 111 0.9× 459 4.2× 39 1.1k
Shinji Kishi Japan 14 310 0.7× 207 0.6× 13 0.1× 226 1.8× 95 0.9× 55 967
Kosaku Nitta Japan 15 127 0.3× 91 0.2× 406 1.7× 36 0.3× 60 0.5× 47 808

Countries citing papers authored by Kolitha Basnayake

Since Specialization
Citations

This map shows the geographic impact of Kolitha Basnayake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kolitha Basnayake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kolitha Basnayake more than expected).

Fields of papers citing papers by Kolitha Basnayake

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kolitha Basnayake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kolitha Basnayake. The network helps show where Kolitha Basnayake may publish in the future.

Co-authorship network of co-authors of Kolitha Basnayake

This figure shows the co-authorship network connecting the top 25 collaborators of Kolitha Basnayake. A scholar is included among the top collaborators of Kolitha Basnayake based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kolitha Basnayake. Kolitha Basnayake is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Lonati, Caterina, Francesco Bellocchio, Alessandro Pizzo, et al.. (2023). Chronic kidney disease-associated pruritus (CKD-aP) is associated with worse quality of life and increased healthcare utilization among dialysis patients. Quality of Life Research. 32(10). 2939–2950. 9 indexed citations
2.
3.
Basnayake, Kolitha, et al.. (2019). Secretion of IL-1β From Monocytes in Gout Is Redox Independent. Frontiers in Immunology. 10. 70–70. 30 indexed citations
4.
Sandeman, Susan, Yishan Zheng, Ganesh Ingavle, et al.. (2017). A haemocompatible and scalable nanoporous adsorbent monolith synthesised using a novel lignin binder route to augment the adsorption of poorly removed uraemic toxins in haemodialysis. Biomedical Materials. 12(3). 35001–35001. 29 indexed citations
5.
Yadav, Punit, Colin A. Hutchison, Kolitha Basnayake, et al.. (2015). Patients with multiple myeloma have excellent long‐term outcomes after recovery from dialysis‐dependent acute kidney injury. European Journal Of Haematology. 96(6). 610–617. 16 indexed citations
6.
Sandeman, Susan, Carol A. Howell, Gary Phillips, et al.. (2014). An adsorbent monolith device to augment the removal of uraemic toxins during haemodialysis. Journal of Materials Science Materials in Medicine. 25(6). 1589–1597. 25 indexed citations
7.
Hutchison, Colin A., Stephen J. Harding, Kolitha Basnayake, et al.. (2014). Serum Polyclonal Immunoglobulin Free Light Chain Levels Predict Mortality in People With Chronic Kidney Disease. Mayo Clinic Proceedings. 89(5). 615–622. 39 indexed citations
8.
Basnayake, Kolitha, Stephanie Stringer, Colin A. Hutchison, & Paul Cockwell. (2011). The biology of immunoglobulin free light chains and kidney injury. Kidney International. 79(12). 1289–1301. 83 indexed citations
9.
Stringer, Stephanie, Kolitha Basnayake, Colin A. Hutchison, & Paul Cockwell. (2011). Recent Advances in the Pathogenesis and Management of Cast Nephropathy (Myeloma Kidney). Europe PMC (PubMed Central). 2011. 1–9. 11 indexed citations
10.
Basnayake, Kolitha, Chee Kay Cheung, Michael Sheaff, et al.. (2010). Differential progression of renal scarring and determinants of late renal recovery in sustained dialysis dependent acute kidney injury secondary to myeloma kidney. Journal of Clinical Pathology. 63(10). 884–887. 24 indexed citations
11.
Basnayake, Kolitha, Wei‐Zhong Ying, Peixuan Wang, & Paul W. Sanders. (2010). Immunoglobulin Light Chains Activate Tubular Epithelial Cells through Redox Signaling. Journal of the American Society of Nephrology. 21(7). 1165–1173. 42 indexed citations
12.
Ying, Wei‐Zhong, et al.. (2010). Immunoglobulin light chains activate nuclear factor-κB in renal epithelial cells through a Src-dependent mechanism. Blood. 117(4). 1301–1307. 56 indexed citations
13.
Hutchison, Colin A., Kolitha Basnayake, & Paul Cockwell. (2009). Serum free light chain assessment in monoclonal gammopathy and kidney disease. Nature Reviews Nephrology. 5(11). 621–628. 41 indexed citations
14.
Hutchison, Colin A., A.R. Bradwell, Mark Cook, et al.. (2009). Treatment of Acute Renal Failure Secondary to Multiple Myeloma with Chemotherapy and Extended High Cut-Off Hemodialysis. Clinical Journal of the American Society of Nephrology. 4(4). 745–754. 164 indexed citations
15.
Hutchison, Colin A., Tim Plant, Mark T. Drayson, et al.. (2008). Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure. BMC Nephrology. 9(1). 11–11. 140 indexed citations
16.
Hutchison, Colin A., Kolitha Basnayake, Mark Cook, Paul Cockwell, & A.R. Bradwell. (2008). 101: High Renal Recovery Rate from Cast Nephropathy Following Free Light Chain Removal Hemodialysis. American Journal of Kidney Diseases. 51(4). B53–B53. 1 indexed citations
17.
Basnayake, Kolitha, Colin A. Hutchison, Dia Kamel, et al.. (2008). Resolution of cast nephropathy following free light chain removal by haemodialysis in a patient with multiple myeloma: a case report. Journal of Medical Case Reports. 2(1). 380–380. 16 indexed citations
18.
Hutchison, Colin A., Mark Cook, Supratik Basu, et al.. (2007). Combined Chemotherapy and High Cut-Off Hemodialysis Improve Outcomes in Multiple Myeloma Patients with Severe Renal Failure.. Blood. 110(11). 3610–3610. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by DJ Roe Breakdown of academic impact, for papers by Julie Abraham Breakdown of academic impact, for papers by Zheng Tang Breakdown of academic impact, for papers by Guillaume Bollée Breakdown of academic impact, for papers by Carlos M. de Castro Breakdown of academic impact, for papers by Mansour Alfayez Breakdown of academic impact, for papers by Claudio Ponticelli Breakdown of academic impact, for papers by Y Beguin Breakdown of academic impact, for papers by Shinji Kishi Breakdown of academic impact, for papers by Kosaku Nitta
Rankless by CCL
2026